{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T22:48:55Z","timestamp":1791154135244,"version":"4.1.0"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,1,1]]},"DOI":"10.1097\/qai.0b013e31818ce709","type":"journal-article","created":{"date-parts":[[2008,12,16]],"date-time":"2008-12-16T03:40:27Z","timestamp":1229398827000},"page":"19-26","source":"Crossref","is-referenced-by-count":34,"title":["Early Control of HIV-1 Infection in Long-Term Nonprogressors Followed Since Diagnosis in the ANRS SEROCO\/HEMOCO Cohort"],"prefix":"10.1097","volume":"50","author":[{"given":"Yoann","family":"Madec","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faroudy","family":"Boufassa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronique","family":"Avettand-Fenoel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia","family":"Hendou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeline","family":"Melard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soraya","family":"Boucherit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janina","family":"Surzyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Rouzioux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210131","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/01.qai.0000186362.50457.e0","article-title":"Spanish HIV-1-infected long-term nonprogressors of more than 15 years have an increased frequency of the CX3CR1 249I variant allele.","volume":"40","author":"Vidal","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R2-3-20210131","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/(SICI)1096-9071(199907)58:3<256::AID-JMV11>3.0.CO;2-Z","article-title":"Status of long-term asymptomatic HIV-1 infection correlates with viral load but not with virus replication properties and cell tropism. French ALT Study Group.","volume":"58","author":"Candotti","year":"1999","journal-title":"J Med Virol"},{"key":"R3-3-20210131","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/00002030-200405210-00004","article-title":"Differences in disease progression in a cohort of long-term non-progressors after more than 16 years of HIV-1 infection.","volume":"18","author":"Rodes","year":"2004","journal-title":"AIDS"},{"key":"R4-3-20210131","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/00002030-200001280-00004","article-title":"CCR5 promoter polymorphisms, CCR5 59029A and CCR5 59353C, are under represented in HIV-1-infected long-term non-progressors. The Australian Long-Term Non-Progressor Study Group.","volume":"14","author":"Clegg","year":"2000","journal-title":"AIDS"},{"key":"R5-3-20210131","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/00042560-199712150-00018","article-title":"Long-term nonprogression in HIV infection. Clinical Epidemiology Group from the Centre dInformation et de Soins de lImmunodeficience Humaine.","volume":"16","author":"Salhi","year":"1997","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"R6-3-20210131","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00042560-199703010-00008","article-title":"How many HIV-infected individuals may be defined as long-term nonprogressors? A report from the Italian Seroconversion Study. Italian Seroconversion Study Group (ISS).","volume":"14","author":"Petrucci","year":"1997","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"R7-3-20210131","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/00002030-199408000-00023","article-title":"Non-progression in HIV infection.","volume":"8","author":"Easterbrook","year":"1994","journal-title":"AIDS"},{"key":"R8-3-20210131","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1086\/314757","article-title":"Longitudinal quantification of human immunodeficiency virus type 1 DNA and RNA in long-term nonprogressors.","volume":"179","author":"Brostrom","year":"1999","journal-title":"J Infect Dis"},{"key":"R9-3-20210131","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1086\/430320","article-title":"Combination of HIV-1-specific CD4 Th1 cell responses and IgG2 antibodies is the best predictor for persistence of long-term nonprogression.","volume":"191","author":"Martinez","year":"2005","journal-title":"J Infect Dis"},{"key":"R10-3-20210131","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00282-996-0193-7","article-title":"HEMOCO: a French prospective study of hemophiliacs infected by human immunodeficiency virus type 1 (HIV-1).","volume":"38","author":"Boufassa","year":"1996","journal-title":"Hematol Cell Ther"},{"key":"R11-3-20210131","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/ije\/27.5.897","article-title":"Predictive value of viral load and other markers for progression to clinical AIDS after CD4+ cell count falls below 200\/microL. SEROCO HEMOCO Study Group.","volume":"27","author":"Carre","year":"1998","journal-title":"Int J Epidemiol"},{"key":"R12-3-20210131","first-page":"659","article-title":"UK Register of HIV Seroconverters Steering Committee.","volume":"12","year":"1998","journal-title":"AIDS"},{"key":"R13-3-20210131","first-page":"224","article-title":"Europe: results from CASCADE.","volume":"1","year":"2000","journal-title":"HIV Med"},{"key":"R14-3-20210131","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/QAI.0b013e3180640cf5","article-title":"Impact of HIV-1 genetic diversity on plasma HIV-1 RNA auantification: usefulness of the Agence Nationale de Recherches sur le SIDA second-generation long terminal repeat-based real-time reverse transcriptase polymerase chain reaction test.","volume":"45","author":"Rouet","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R15-3-20210131","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00002030-200001280-00007","article-title":"Natural history of serum HIV-1 RNA levels in 330 patients with a known date of infection. The SEROCO Study Group.","volume":"14","author":"Hubert","year":"2000","journal-title":"AIDS"},{"key":"R16-3-20210131","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1086\/500213","article-title":"CD4 cell count and HIV DNA level are independent predictors of disease progression after primary HIV type 1 infection in untreated patients.","volume":"42","author":"Goujard","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R17-3-20210131","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00042560-199806010-00007","article-title":"Longitudinal HIV-1 RNA levels in a cohort of homosexual men.","volume":"18","author":"OBrien","year":"1998","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"R18-3-20210131","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/infdis\/175.2.247","article-title":"Longitudinal analysis of quantitative virologic measures in human immunodeficiency virus-infected subjects with or = 400 CD4 l 400 CD4 lymphocytes: implications for applying measurements to individual patients. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group.","volume":"175","author":"Paxton","year":"1997","journal-title":"J Infect Dis"},{"key":"R19-3-20210131","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/00126334-200309010-00012","article-title":"Differences in CD4 cell counts at seroconversion and decline among 5739 HIV-1-infected individuals with well-estimated dates of seroconversion.","volume":"34","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R20-3-20210131","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1097\/01.aids.0000131341.45795.33","article-title":"Do patients who are infected with drug-resistant HIV have a different CD4 cell decline after seroconversion? An exploratory analysis in the UK Register of HIV Seroconverters.","volume":"18","author":"Bhaskaran","year":"2004","journal-title":"AIDS"},{"key":"R21-3-20210131","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1097\/01.aids.0000194134.28135.cd","article-title":"Spontaneous control of viral load and CD4 cell count progression among HIV-1 seroconverters.","volume":"19","author":"Madec","year":"2005","journal-title":"AIDS"},{"key":"R22-3-20210131","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/01.aids.0000161765.75663.27","article-title":"Sex and the course of HIV infection in the pre- and highly active antiretroviral therapy eras.","volume":"19","author":"Prins","year":"2005","journal-title":"AIDS"},{"key":"R23-3-20210131","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1742-6405-4-11","article-title":"Predictors of disease progression in HIV infection: a review.","volume":"4","author":"Langford","year":"2007","journal-title":"AIDS Res Ther"},{"key":"R24-3-20210131","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1086\/433188","article-title":"HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication.","volume":"41","author":"Lambotte","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R25-3-20210131","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1086\/430610","article-title":"Early levels of HIV-1 DNA in peripheral blood mononuclear cells are predictive of disease progression independently of HIV-1 RNA levels and CD4+ T cell counts.","volume":"192","author":"Rouzioux","year":"2005","journal-title":"J Infect Dis"},{"key":"R26-3-20210131","doi-asserted-by":"crossref","first-page":"946","DOI":"10.7326\/0003-4819-126-12-199706150-00003","article-title":"Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection.","volume":"126","author":"Mellors","year":"1997","journal-title":"Ann Intern Med"},{"key":"R27-3-20210131","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1086\/315339","article-title":"Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study.","volume":"181","author":"Lyles","year":"2000","journal-title":"J Infect Dis"},{"key":"R28-3-20210131","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1126\/science.272.5265.1167","article-title":"Prognosis in HIV-1 infection predicted by the quantity of virus in plasma.","volume":"272","author":"Mellors","year":"1996","journal-title":"Science"},{"key":"R29-3-20210131","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/QAI.0b013e318189a739","article-title":"Rapid CD4+ cell decrease after transient cART initiated during primary HIV infection (ANRS PRIMO and SEROCO cohorts).","volume":"49","author":"Seng","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R30-3-20210131","first-page":"2361","article-title":"Does transient HAART during primary HIV-1 infection lower the virological set-point?","volume":"18","author":"Desquilbet","year":"2004","journal-title":"AIDS"},{"key":"R31-3-20210131","doi-asserted-by":"crossref","first-page":"6776","DOI":"10.1073\/pnas.0611244104","article-title":"HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype.","volume":"104","author":"Saez-Cirion","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R32-3-20210131","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1089\/088922201753197105","article-title":"HIV type 1-specific IgG2 antibodies: markers of helper T cell type 1 response and prognostic marker of long-term nonprogression.","volume":"17","author":"Ngo-Giang-Huong","year":"2001","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R33-3-20210131","first-page":"89","article-title":"Progression of HIV to AIDS: a protective role for HLA-B27?","volume":"6","author":"den Uyl","year":"2004","journal-title":"AIDS Rev"},{"key":"R34-3-20210131","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1086\/518515","article-title":"Evolution of HIV-1 in an HLA-B*57-posi57-positive patient during virologic escape.","volume":"196","author":"Bailey","year":"2007","journal-title":"J Infect Dis"},{"key":"R35-3-20210131","doi-asserted-by":"crossref","first-page":"10099","DOI":"10.1128\/JVI.76.20.10099-10108.2002","article-title":"Quantitation of human immunodeficiency virus type 1 DNA forms with the second template switch in peripheral blood cells predicts disease progression independently of plasma RNA load.","volume":"76","author":"Kostrikis","year":"2002","journal-title":"J Virol"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/QAI.0b013e31818ce709","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:27:21Z","timestamp":1786037241000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00126334-200901010-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e31818ce709","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1,1]]}}}